English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Aim. To compare the effectiveness of treatment of destructive, bacillary pulmonary tuberculosis in newonset patients treated with standard chemotherapy and in patients who used complex magnetic-infrared-laser therapy (MIL-therapy) on the background of standard treatment of tuberculosis. Material and methods. The main group of 45 people received MIL-therapy on a background of standard chemotherapy, comparison group, 45 people received chemotherapy and vitamin therapy. Results and discussion. It was found that intoxication syndrome relief by the end of the first month was observed in 62,8% of patients of the main group, and in 40,6% of patients in the control group. Expressed or moderate resorption of infiltrative changes by the end of 2 months treatment was observed in 53,3% of patients in study group, and 24,4% in control group. Abacillation of mucus after three months of treatment was observed in 82,2% of patients of main group, and 51,1% of patients in control group. Cavities of decay were eliminated from 57,8% in study group and 8,8% of patients in control group after 6 months of treatment. Conclusion. Application of MIL-therapy on the affected lung’s projection enhances the effect of antibiotic treatment of destructive pulmonary tuberculosis due to the multi-faceted, complex effects on the main pathogenetic mechanisms of specific inflammation.

Results of using magnetic-infRaRed-laseR theRapy in complex tReatment of patients with new-onset destRuctive pulmonaRy tubeRculosis